Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Author: Benzinga Insights | May 09, 2023 09:06am

Gainers

  • TScan Therapeutics (NASDAQ:TCRX) stock rose 61.8% to $3.64 during Tuesday's pre-market session. The company's market cap stands at $89.6 million.
  • Erytech Pharma (NASDAQ:ERYP) stock increased by 47.49% to $1.18. The company's market cap stands at $36.5 million.
  • Ensysce Biosciences (NASDAQ:ENSC) stock increased by 42.15% to $4.89. The market value of their outstanding shares is at $6.2 million.
  • Synlogic (NASDAQ:SYBX) stock moved upwards by 23.21% to $0.69. The company's market cap stands at $46.7 million.
  • Novavax (NASDAQ:NVAX) shares rose 20.93% to $9.01. The company's market cap stands at $776.4 million. As per the press release, Q1 earnings came out today.
  • Tactile Systems Tech (NASDAQ:TCMD) stock rose 17.12% to $21.95. The company's market cap stands at $509.9 million. As per the press release, Q1 earnings came out yesterday.

Losers

  • Enanta Pharma (NASDAQ:ENTA) stock decreased by 30.3% to $23.93 during Tuesday's pre-market session. The company's market cap stands at $499.8 million. As per the press release, Q2 earnings came out yesterday.
  • Lexaria Bioscience (NASDAQ:LEXX) shares decreased by 27.81% to $0.74. The company's market cap stands at $4.4 million.
  • AdaptHealth (NASDAQ:AHCO) shares decreased by 20.05% to $9.65. The market value of their outstanding shares is at $1.3 billion. The company's, Q1 earnings came out today.
  • Bellicum Pharmaceuticals (NASDAQ:BLCM) shares declined by 16.66% to $0.8. The company's market cap stands at $7.2 million.
  • Coherus BioSciences (NASDAQ:CHRS) shares fell 15.85% to $6.85. The market value of their outstanding shares is at $551.7 million. The company's, Q1 earnings came out yesterday.
  • Acorda Therapeutics (NASDAQ:ACOR) stock declined by 15.39% to $0.74. The market value of their outstanding shares is at $18.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ACOR AHCO BLCM CHRS ENSC ENTA ERYP LEXX NVAX SYBX TCMD TCRX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist